Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Leucovorin
Related studies linked through entity extraction aliases.
A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Colorectal Cancer (CRC) Cetuximab Elderly Frail
- Status
- TERMINATED
- Phase
- PHASE2
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response
- Status
- TERMINATED
- Phase
- PHASE1